Navigation Links
Primary androgen deprivation therapy ineffective for most men with early prostate cancer
Date:3/17/2014

WASHINGTON A study of more than 15,000 men with early stage prostate cancer finds that those who received androgen deprivation as their primary treatment instead of surgery or radiation did not live any longer than those who received no treatment.

The research team, led by scientists at Georgetown Lombardi Comprehensive Cancer Center, say that the risks of serious adverse events associated with the treatment which has been linked to impaired cognition, heart disease, diabetes and other disorders "mitigates against any clinical or policy rationale for use of primary androgen deprivation therapy in these men."

The findings, reported Monday in the Journal of Clinical Oncology, draw from cancer registries linked with extensive electronic medical records in three, large integrated health plans. The men included in the study had prostate cancer that had not spread beyond the organ (localized) and did not have surgery or radiation therapy, considered curative treatment.

Androgen deprivation therapy suppresses the production of testosterone, the male hormone said to fuel growth of prostate cancer. The therapy improves survival when given with radiation for later stages of disease, and is considered the standard of care for men who have metastatic prostate cancer. Effectiveness of primary androgen deprivation therapy (PADT) has not been established.

"This study is the most comprehensive study on the effectiveness of PADT for men who forgo radiation and surgery for their localized prostate cancer, and it tells us there is no strong reason to use it in most patients," says the study's lead investigator, Arnold Potosky, PhD, a professor of oncology and director of health services research at Georgetown Lombardi. "We found only a small survival benefit for primary androgen deprivation therapy compared to no therapy in men diagnosed with higher-risk localized prostate cancer."

Use of primary androgen deprivation therapy for early stage prosta
'/>"/>

Contact: Karen Teber
km463@georgetown.edu
Georgetown University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Rural primary care physicians are committed to professionalism, quality improvement
2. New study shows core factors and strategies to turn primary care practices into PCMHs
3. Katie Johnson, Author of Red Flags for Primary Teachers, Works with Fifth Graders to Investigate Their VIsion Problems When Reading
4. Live Primary Care CME (Continuing Medical Education) Faculty and Agenda Announced for Presidents' Week Conference in February 2014 to Be Held in Maui, Hawaii
5. Sunflower Medical Group Opens New Heartland Primary Care Location in Lenexa with Urgent Care Clinic
6. Center for Primary Care Celebrates 20th Anniversary
7. Primary care key to management of patients with HIV infection
8. Expanding primary care capacity by reducing inefficiency
9. Red Flags for Primary Teachers, Katie Johnson's Book about Children's Vision, Wins in The Great Midwest Book Festival Contest
10. Anxiety help comes, eventually, via primary care
11. Physician shortage could be cut by new primary care models, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 Florida Hospital and MOSI officially announced ... for years to come and make a difference in the ... million dollar check to provide the support needed to keep ... MOSI to transform the IMAX Dome Theatre from film to ... only IMAX Dome Theatre in the state of Florida, and ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Merrill ... of technology-enabled services for the financial, legal, healthcare ... virtual data room business, Merrill DataSite, has been ... presented by GrowthBusiness at the M&A Awards 2014 ... the achievements of entrepreneurs, management teams, advisors and ...
(Date:7/25/2014)... A new study conducted by the Hospital for ... of all children in the survey under the age of four ... 2,505 children during the years of 2011 and 2013. The children ... The final result was that about two out of every five ... were from lower-income families and were of East Asian heritage. , ...
(Date:7/25/2014)... Parker Waichman LLP, a national law firm ... a recent tobacco lawsuit in which a Florida jury ... punitive damages. Cynthia Robinson brought the lawsuit against R.J. ... Cynthia Robinson v. R.J. Reynolds Tobacco Company and was ... Escambia County, Florida; Case Number 2008 CA 000098. , ...
(Date:7/25/2014)... Dallas, TX (PRWEB) July 25, 2014 ... on the current state of the Galactooligosaccharides (GOS) ... provides a basic overview of the industry, including ... analysis and Chinese domestic market analysis are provided ... competitive landscape of the market. A comparison between ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4Health News:Merrill DataSite Recognized as “Technology Provider of the Year” by GrowthBusiness at the M&A Awards 2014 Event 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 3Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3
... Quigley,Corporation (Nasdaq: QGLY ) today reported net sales ... ended March 31, 2008,compared to $6.1 million reported for ... of 2008 reflects a net sales decrease for the,Company,s ... first quarter,of 2007. The change during 2008 as compared ...
... Company to Host Conference Call at 4:30 p.m. EDT Today ... PCYC ) today reported financial results for its third fiscal,quarter ... quarter of fiscal,2008 was $7.0 million, or $0.27 per share, ... share, in the third quarter of fiscal 2007., Total ...
... Actavis Group, the,international generic pharmaceuticals company, today ... study on the Company and its President,and CEO. ... was presented in an MBA class in international ... made available to business,schools around the world., ...
... Act on Capitol Hill, WASHINGTON, April 24 ... and questions for the patient, their families and,caregivers. ... cancer care by affording the patient the opportunity ... thought the cancer diagnosis, treatment,and follow up care., ...
... April 24 The Asthma and Allergy,Foundation of America ... today -- the most challenging places to live for ... year for many allergy,sufferers from Lexington, KY (ranked #1), ... Allergy Capitals based on the impact that key,environmental and ...
... Association urges Senators Boxer and Feinstein to quickly pass,companion ... April 23 AARP thanked,the supporters and cosponsors of ... passed today in the U.S. House of Representatives. The ... by stopping,harmful cuts proposed by the administration., "Today,s ...
Cached Medicine News:Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 2Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 3Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 4Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 5Health News:Pharmacyclics Reports Third Quarter 2008 Financial Results 2Health News:Pharmacyclics Reports Third Quarter 2008 Financial Results 3Health News:Pharmacyclics Reports Third Quarter 2008 Financial Results 4Health News:Pharmacyclics Reports Third Quarter 2008 Financial Results 5Health News:Pharmacyclics Reports Third Quarter 2008 Financial Results 6Health News:Harvard Business School Publishes a Case Study on Robert Wessman and Actavis 2Health News:Harvard Business School Publishes a Case Study on Robert Wessman and Actavis 3Health News:Support for Patient Navigation Services to Help Cancer Patients 2Health News:2008 Spring Allergy Capitals Announced 2Health News:AARP Thanks California's Representatives for Supporting Bill to Protect People in Medicaid 2
(Date:7/25/2014)... , July 25, 2014  Depomed, Inc. (NASDAQ: ... second quarter fiscal year 2014 financial results after the ... host a conference call beginning at 4:30 pm EDT, 1:30 ... access the call by dialing 877-317-6789 ( United ... will also be available via a live webcast on ...
(Date:7/25/2014)... LAS VEGAS , July 25, 2014 GrowBLOX ... of a binding Memorandum of Understanding ("MOU") with LaurelCo, LLC, ... to pursue the acquisition of both cultivation and dispensary medical ... . Pursuant to the MOU, GBLX will acquire a 20% ... use our proprietary GrowBLOX TM growing chambers, as well ...
(Date:7/25/2014)... ALBANY, New York , July 25, 2014 /PRNewswire/ ... published by Transparency Market Research "Global and China Insulin ... Insulin) - Industry Analysis, Size, Share, Growth, Trends and ... insulin market was valued at USD 19.99 billion in ... of 6.1% from 2013 to 2019 to reach USD ...
Breaking Medicine Technology:Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4
... CVS Caremark Corporation (NYSE: CVS ) today announced that Tom Ryan , Chairman, President and CEO, ... to investors at the Barclays Capital 2010 Global Healthcare Conference on March 23, 2010 . The Company is ... ... , ...
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended ... ... ... ...
Cached Medicine Technology:CVS Caremark to Present at the Barclays Capital 2010 Global Healthcare Conference 2CVS Caremark to Present at the Barclays Capital 2010 Global Healthcare Conference 3BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 5BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 6BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 7BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 9BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 10BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 11BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 12BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 13
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: